ARCHIVES

Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

Weicker Compromise on 6,000 Grants For Two Years Holds Up; New Waxman Bill Would Renew Cancer Act

May 17, 1985

In Brief: NCI Thinks Puerto Rico Should Have Comprehensive Center; President Says He Won’t Oppose NIH Budget Increases

April 26, 1974

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

Drug Discovery Group Announcement Issued

January 7, 1983

Blumenthal Says Action Plan To Issue “New Priority Areas”

October 24, 1996